(Q40639767)

22 September 2017

A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics (English)

1 reference

22 September 2017

1 reference

1 reference

5

Robert M Hoffman

1 reference

22 September 2017

Matthew H Katz

1

1 reference

22 September 2017

Shinako Takimoto

2

1 reference

22 September 2017

Daniel Spivack

3

1 reference

22 September 2017

A R Moossa

4

1 reference

22 September 2017

Michael Bouvet

6

1 reference

22 September 2017

1 July 2003

1 reference

Journal of Surgical Research

22 September 2017

1 reference

22 September 2017

113

1 reference

22 September 2017

151-160

1 reference

22 September 2017

1

1 reference

An orthotopic in vivo model of human pancreatic cancer

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Fluorescent proteins from nonbioluminescent Anthozoa species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Factors influencing survival after resection for periampullary neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Phase II study of gemcitabine in patients with advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy:correlations of a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

Establishment of a nude mouse model of hepatic metastasis for evaluation of targeted retroviral gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

A new peritoneal dissemination model established from the human pancreatic cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900234-8

10.1016/S0022-4804(03)00234-8

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference